This inventor holds 1 USPTO granted patent. Top assignee: Creagene Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovations of Dong-Sung Lee
Introduction
Dong-Sung Lee is a notable inventor based in Daejeon Metropolitan, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines. His work focuses on enhancing the safety and efficacy of poliovirus vaccines.
Latest Patents
Dong-Sung Lee holds a patent for an advanced oral poliovirus vaccine (Adv-OPV) that is designed to eliminate the risk of vaccine-associated paralytic poliomyelitis (VAPP). This innovative invention involves a recombinant Sabin type 1 poliovirus vector that enhances the immunogenicity of neutralizing antibodies against polioviral infection. The patent includes a genomic nucleotide sequence of a parent Sabin type 1 poliovirus, an additional polioviral cleavage site, and a conformational epitope encoding a VP1 neutralizing epitope of poliovirus types 2 or 3.
Career Highlights
Dong-Sung Lee is currently associated with Creagene Inc., where he continues to advance his research in vaccine development. His work has been instrumental in addressing public health challenges related to poliovirus.
Collaborations
He collaborates with esteemed colleagues such as Yong-Soo Bae and Sang-Gu Lee, contributing to a dynamic research environment that fosters innovation.
Conclusion
Dong-Sung Lee's contributions to vaccine development, particularly through his patent on the advanced oral poliovirus vaccine, highlight his commitment to improving public health. His work exemplifies the impact of innovative research in combating infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile